#613424
Table of Contents
Other entities represented in this entry:
A number sign (#) is used with this entry because this form of dilated cardiomyopathy (CMD1R) is caused by heterozygous mutation in the ACTC1 gene (102540) on chromosome 15q14.
Mutation in the ACTC1 gene has also been associated with left ventricular noncompaction (LVNC4), hypertrophic cardiomyopathy (CMH11; 612098), and atrial septal defects (ASD5; 612794).
For a general phenotypic description and a discussion of genetic heterogeneity of dilated cardiomyopathy, see CMD1A (115200); for a similar discussion of left ventricular noncompaction, see LVNC1 (604169).
Olson et al. (1998) studied 2 unrelated families with autosomal dominant idiopathic dilated cardiomyopathy (CMD), one of German ancestry and the other of Swedish Norwegian ancestry. Families were phenotypically characterized by echocardiography, with CMD being defined as left ventricular end-diastolic dimension (LVEDD) greater than the 95th percentile for age and body surface area, and shortening fraction less than 28%. Individuals in both families had variable age at diagnosis (1 to 41 years), similar to other CMD families, with age at diagnosis differing by as much as 20 to 50 years. Heart biopsy specimens from the proband of each family revealed histopathologic findings consistent with CMD, showing moderate focal interstitial fibrosis and myocyte hypertrophy, but no evidence of myocarditis or of the myofibrillar disarray seen in hypertrophic cardiomyopathy (CMH).
In affected members of 2 unrelated families with dilated cardiomyopathy, Olson et al. (1998) identified heterozygosity for 2 different mutations in the ACTC1 gene (102540.0001 and 102540.0002, respectively).
Takai et al. (1999) analyzed the ACTC1 gene in 136 Japanese CMD patients, but found no disease-causing mutations. They concluded that mutation in the ACTC1 gene is a rare cause of CMD, at least in Japanese patients.
Mayosi et al. (1999) studied 57 South African patients with dilated cardiomyopathy, 56% of whom were of black African origin. No mutation predicted to produce an alteration in protein was identified in either the skeletal or cardiac actin genes in any patient.
Left Ventricular Noncompaction 4
Monserrat et al. (2007) screened 247 probands with CMD, hypertrophic cardiomyopathy (see CMH11, 612098), or left ventricular noncompaction (LVNC) for the E101K mutation in the ACTC1 gene (102540.0009) and identified the mutation in 4 probands diagnosed with CMH and 1 with LVNC. The 5 mutation-positive families, 2 of which were previously studied by Arad et al. (2005), were all from the same local area in Galicia, Spain, and shared the same 88-bp allele of the intragenic ACTC1 microsatellite marker that cosegregated with disease in the families, suggesting a likely founder effect. All 46 mutation-positive members of the 5 families had increased maximum left ventricular wall thickness, usually with prominent trabeculations and deep invaginations in the thickened segments, and 23 patients fulfilled criteria for LVNC; 22 were diagnosed with apical CMH, and 3 with restrictive cardiomyopathy. Septal defects were identified in 9 mutation carriers from 4 families, including 8 atrial defects and 1 ventricular defect, and were absent in relatives without the mutation. Monserrat et al. (2007) concluded that LVNC and CMH may appear as overlapping entities, and that the E101K mutation in ACTC1 should be considered in the genetic diagnosis of LVNC, apical CMH, and septal defects.
Klaassen et al. (2008) analyzed 6 genes encoding sarcomere proteins in 63 unrelated adult probands with LVNC but no other congenital heart anomalies, and identified the E101K mutation in the ACTC1 gene in a 15-year-old girl and a 38-year-old woman. Both had inherited the mutation from their affected fathers; haplotype analysis excluded a common ancestor. All 4 patients had noncompaction of the apex and midventricular wall. The 15-year-old girl, who was originally diagnosed with CMH, had syncope and hypoxic brain damage and underwent pacemaker implantation; her 58-year-old father had syncope, congestive heart failure (CHF), and pulmonary hypertension (PHT). The 38-year-old woman had CHF and PHT, whereas her 73-year-old father had no cardiovascular complications.
Arad, M., Penas-Lado, M., Monserrat, L., Maron, B. J., Sherrid, M., Ho, C. Y., Barr, S., Karim, A., Olson, T. M., Kamisago, M., Seidman, J. G., Seidman, C. E. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112: 2805-2811, 2005. [PubMed: 16267253, related citations] [Full Text]
Klaassen, S., Probst, S., Oechslin, E., Gerull, B., Krings, G., Schuler, P., Greutmann, M., Hurlimann, D., Yegibasi, M., Pons, L., Gramlich, M., Drenckhahn, J.-D., Heuser, A., Berger, F., Jenni, R., Thierfelder, L. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 117: 2893-2901, 2008. [PubMed: 18506004, related citations] [Full Text]
Mayosi, B. M., Khogali, S. S., Zhang, B., Watkins, H. Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J. Med. Genet. 36: 796-797, 1999. [PubMed: 10528865, related citations] [Full Text]
Monserrat, L., Hermida-Prieto, M., Fernandez, X., Rodriguez, I., Dumont, C., Cazon, L., Cuesta, M. G., Gonzalez-Juanatey, C., Peteiro, J., Alvarez, N., Penas-Lado, M., Castro-Beiras, A. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Europ. Heart J. 28: 1953-1961, 2007. [PubMed: 17611253, related citations] [Full Text]
Olson, T. M., Michels, V. V., Thibodeau, S. N., Tai, Y.-S., Keating, M. T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280: 750-752, 1998. [PubMed: 9563954, related citations] [Full Text]
Takai, E., Akita, H., Shiga, N., Kanazawa, K., Yamada, S., Terashima, M., Matsuda, Y., Iwai, C., Kawai, K., Yokota, Y., Yokoyama, M. Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy. Am. J. Med. Genet. 86: 325-327, 1999. [PubMed: 10494087, related citations] [Full Text]
Other entities represented in this entry:
ORPHA: 154, 54260; DO: 0110456;
| Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
|---|---|---|---|---|---|---|
| 15q14 | Cardiomyopathy, dilated, 1R | 613424 | Autosomal dominant | 3 | ACTC1 | 102540 |
| 15q14 | Left ventricular noncompaction 4 | 613424 | Autosomal dominant | 3 | ACTC1 | 102540 |
A number sign (#) is used with this entry because this form of dilated cardiomyopathy (CMD1R) is caused by heterozygous mutation in the ACTC1 gene (102540) on chromosome 15q14.
Mutation in the ACTC1 gene has also been associated with left ventricular noncompaction (LVNC4), hypertrophic cardiomyopathy (CMH11; 612098), and atrial septal defects (ASD5; 612794).
For a general phenotypic description and a discussion of genetic heterogeneity of dilated cardiomyopathy, see CMD1A (115200); for a similar discussion of left ventricular noncompaction, see LVNC1 (604169).
Olson et al. (1998) studied 2 unrelated families with autosomal dominant idiopathic dilated cardiomyopathy (CMD), one of German ancestry and the other of Swedish Norwegian ancestry. Families were phenotypically characterized by echocardiography, with CMD being defined as left ventricular end-diastolic dimension (LVEDD) greater than the 95th percentile for age and body surface area, and shortening fraction less than 28%. Individuals in both families had variable age at diagnosis (1 to 41 years), similar to other CMD families, with age at diagnosis differing by as much as 20 to 50 years. Heart biopsy specimens from the proband of each family revealed histopathologic findings consistent with CMD, showing moderate focal interstitial fibrosis and myocyte hypertrophy, but no evidence of myocarditis or of the myofibrillar disarray seen in hypertrophic cardiomyopathy (CMH).
In affected members of 2 unrelated families with dilated cardiomyopathy, Olson et al. (1998) identified heterozygosity for 2 different mutations in the ACTC1 gene (102540.0001 and 102540.0002, respectively).
Takai et al. (1999) analyzed the ACTC1 gene in 136 Japanese CMD patients, but found no disease-causing mutations. They concluded that mutation in the ACTC1 gene is a rare cause of CMD, at least in Japanese patients.
Mayosi et al. (1999) studied 57 South African patients with dilated cardiomyopathy, 56% of whom were of black African origin. No mutation predicted to produce an alteration in protein was identified in either the skeletal or cardiac actin genes in any patient.
Left Ventricular Noncompaction 4
Monserrat et al. (2007) screened 247 probands with CMD, hypertrophic cardiomyopathy (see CMH11, 612098), or left ventricular noncompaction (LVNC) for the E101K mutation in the ACTC1 gene (102540.0009) and identified the mutation in 4 probands diagnosed with CMH and 1 with LVNC. The 5 mutation-positive families, 2 of which were previously studied by Arad et al. (2005), were all from the same local area in Galicia, Spain, and shared the same 88-bp allele of the intragenic ACTC1 microsatellite marker that cosegregated with disease in the families, suggesting a likely founder effect. All 46 mutation-positive members of the 5 families had increased maximum left ventricular wall thickness, usually with prominent trabeculations and deep invaginations in the thickened segments, and 23 patients fulfilled criteria for LVNC; 22 were diagnosed with apical CMH, and 3 with restrictive cardiomyopathy. Septal defects were identified in 9 mutation carriers from 4 families, including 8 atrial defects and 1 ventricular defect, and were absent in relatives without the mutation. Monserrat et al. (2007) concluded that LVNC and CMH may appear as overlapping entities, and that the E101K mutation in ACTC1 should be considered in the genetic diagnosis of LVNC, apical CMH, and septal defects.
Klaassen et al. (2008) analyzed 6 genes encoding sarcomere proteins in 63 unrelated adult probands with LVNC but no other congenital heart anomalies, and identified the E101K mutation in the ACTC1 gene in a 15-year-old girl and a 38-year-old woman. Both had inherited the mutation from their affected fathers; haplotype analysis excluded a common ancestor. All 4 patients had noncompaction of the apex and midventricular wall. The 15-year-old girl, who was originally diagnosed with CMH, had syncope and hypoxic brain damage and underwent pacemaker implantation; her 58-year-old father had syncope, congestive heart failure (CHF), and pulmonary hypertension (PHT). The 38-year-old woman had CHF and PHT, whereas her 73-year-old father had no cardiovascular complications.
Arad, M., Penas-Lado, M., Monserrat, L., Maron, B. J., Sherrid, M., Ho, C. Y., Barr, S., Karim, A., Olson, T. M., Kamisago, M., Seidman, J. G., Seidman, C. E. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112: 2805-2811, 2005. [PubMed: 16267253] [Full Text: https://doi.org/10.1161/CIRCULATIONAHA.105.547448]
Klaassen, S., Probst, S., Oechslin, E., Gerull, B., Krings, G., Schuler, P., Greutmann, M., Hurlimann, D., Yegibasi, M., Pons, L., Gramlich, M., Drenckhahn, J.-D., Heuser, A., Berger, F., Jenni, R., Thierfelder, L. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 117: 2893-2901, 2008. [PubMed: 18506004] [Full Text: https://doi.org/10.1161/CIRCULATIONAHA.107.746164]
Mayosi, B. M., Khogali, S. S., Zhang, B., Watkins, H. Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J. Med. Genet. 36: 796-797, 1999. [PubMed: 10528865] [Full Text: https://doi.org/10.1136/jmg.36.10.796]
Monserrat, L., Hermida-Prieto, M., Fernandez, X., Rodriguez, I., Dumont, C., Cazon, L., Cuesta, M. G., Gonzalez-Juanatey, C., Peteiro, J., Alvarez, N., Penas-Lado, M., Castro-Beiras, A. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Europ. Heart J. 28: 1953-1961, 2007. [PubMed: 17611253] [Full Text: https://doi.org/10.1093/eurheartj/ehm239]
Olson, T. M., Michels, V. V., Thibodeau, S. N., Tai, Y.-S., Keating, M. T. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280: 750-752, 1998. [PubMed: 9563954] [Full Text: https://doi.org/10.1126/science.280.5364.750]
Takai, E., Akita, H., Shiga, N., Kanazawa, K., Yamada, S., Terashima, M., Matsuda, Y., Iwai, C., Kawai, K., Yokota, Y., Yokoyama, M. Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy. Am. J. Med. Genet. 86: 325-327, 1999. [PubMed: 10494087] [Full Text: https://doi.org/10.1002/(sici)1096-8628(19991008)86:4<325::aid-ajmg5>3.0.co;2-u]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM